NCT05628246

Brief Summary

Cancer is the second leading cause of death worldwide, with approximately 18.1 million new cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by 50-70% of patients, with a higher prevalence at advanced disease stages (66.4%). Since the development of WHO's cancer pain guidelines, several studies have reported good relief of symptoms and suffering for a majority of patients. Recent reports suggest that up to 50% of patients still report insufficient pain control. Patients with cancer often present with multiple symptoms and functional decline. Evidence supports multidisciplinary approaches to address symptoms and suffering, including early palliative care referral From review literatures we found that the telemedicine group had significantly higher quality of life than the usual care group. In addition, the telemedicine group had lower anxiety and depression scores than the usual care group. Therefore, we will conduct the non-randomized controlled study of using telemedicine comparing to conventional in-person at OPD in hospitalized cancer pain patients. The purpose of this study is to assess the pain interference by using the Brief Pain Inventory (BPI) and to compare between the in-person group and the telemedicine group. To assess the cost-effectiveness of telemedicine for reducing symptoms associated with cancer and its treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
206

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 28, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

January 19, 2023

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 17, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2025

Completed
Last Updated

January 27, 2023

Status Verified

January 1, 2023

Enrollment Period

2.5 years

First QC Date

November 15, 2022

Last Update Submit

January 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain interference

    The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group.

    at 1 month

Secondary Outcomes (2)

  • Quality of life (QoL)

    at 1 month

  • Pain intensity

    at 1 month, 2 months and 3 months

Study Arms (2)

In-person

ACTIVE COMPARATOR

Face to face at OPD

Other: In-person

Telemedicine

EXPERIMENTAL

Telemedicine

Other: Telemedicine

Interventions

Telemedicine

Telemedicine

In-person

In-person

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age older than 18 years old
  • Cancer patients who new visit as out patient at pain clinic, Siriraj hospital

You may not qualify if:

  • Cannot read and write
  • Confusion
  • Unable to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity.
  • Unstable clinical presentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine Siriraj Hospital Mahidol University

Bangkoknoi, Bangkok, 10700, Thailand

RECRUITING

Related Publications (4)

  • Pang L, Liu Z, Lin S, Liu Z, Liu H, Mai Z, Liu Z, Chen C, Zhao Q. The effects of telemedicine on the quality of life of patients with lung cancer: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020 Oct 7;11:2040622320961597. doi: 10.1177/2040622320961597. eCollection 2020.

  • Wangnamthip S, Panchoowong S, Donado C, Lobo K, Phankhongsap P, Sriveerachai P, Euasobhon P, Rushatamukayanunt P, Mandee S, Zinboonyahgoon N, Berde CB. The Effectiveness of Cancer Pain Management in a Tertiary Hospital Outpatient Pain Clinic in Thailand: A Prospective Observational Study. Pain Res Manag. 2021 Jul 20;2021:5599023. doi: 10.1155/2021/5599023. eCollection 2021.

  • Chaudakshetrin P. Validation of the Thai Version of Brief Pain Inventory (BPI-T) in cancer patients. J Med Assoc Thai. 2009 Jan;92(1):34-40.

  • Pattanaphesaj J, Thavorncharoensap M, Ramos-Goni JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. The EQ-5D-5L Valuation study in Thailand. Expert Rev Pharmacoecon Outcomes Res. 2018 Oct;18(5):551-558. doi: 10.1080/14737167.2018.1494574. Epub 2018 Jul 6.

MeSH Terms

Conditions

Chronic PainCancer Pain

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Suratsawadee Wangnamthip, M.D.

    Mahidol University

    STUDY DIRECTOR

Central Study Contacts

Suratsawadee Wangnamthip, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 15, 2022

First Posted

November 28, 2022

Study Start

January 19, 2023

Primary Completion

July 17, 2025

Study Completion

July 17, 2025

Last Updated

January 27, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations